Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
EPS (Diluted) history
Currency unavailable · from the income statement
No EPS (Diluted) data reported for this period type.
EPS (Diluted) vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -$0.08 USD | -175.4% | — | |
| LTM Mar 2026 | -$0.08 USD | -8.9% | -9.1% | |
| LTM Jun 2026 | -$4.11 USD | +28.0% | — | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | -SEK 9.4 SEK | +3.9% | — |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding AVLN) | — | -2.5% | -9.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.